A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy

被引:0
作者
Daizo Fukushima
Shigeki Imai
Noriyuki Nishino
Kohichi Hamada
Yoshinori Horikawa
Yoshiki Shiwa
Shinya Nishida
Ryota Koyanagi
Hitoshi Wada
Hideo Sakuma
机构
[1] Southern Tohoku General Hospital,Department of Gastroenterology
[2] Southern Tohoku Research Institute for Neuroscience,Department of Radiology
[3] Fukushima Medical University,Department of Minimally Invasive Surgical and Medical Oncology
[4] Southern Tohoku Proton Therapy Center,Department of Radiation Oncology
[5] Southern Tohoku Research Institute for Neuroscience,Department of Pathology
来源
Clinical Journal of Gastroenterology | 2020年 / 13卷
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Arterio-portal shunt; Transarterial chemoembolization; Radiation therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Portal vein tumor thrombosis (PVTT) is an extremely locally advanced form of hepatocellular carcinoma. The natural median survival time of patients with hepatocellular carcinoma with PVTT is 2.7 to 4.0 months. A 63-year-old woman visited our clinic complaining of abdominal distention and appetite loss, which she had had for 3 weeks prior to admission. A contrast-enhanced computed tomography scan showed double hepatocellular carcinomas with Type III PVTT and massive ascites caused by arterio-portal shunts within the PVTT. The ascites could not be treated by concentrated ascites reinfusion therapy or diuretics. Transarterial embolization using microspheres followed by radiation therapy against PVTT and five courses of transarterial chemoembolization using microspheres and cisplatin led to the maintaining of complete remission of both ascites and tumors for over 12 months after treatment. Fluoroglucose accumulation of PVTT showed 11.2 as a maximum standard uptake value on positron emission tomography before treatment. No fluoroglucose accumulation within PVTT was observed for over 12 months following treatment. Transarterial chemoembolization using microspheres followed by radiation therapy against Type III PVTT may result in drastic anti-cancer effects and improvement of both serum albumin and intractable ascites after treatment of arterio-portal shunts within the PVTT causing portal hypertension.
引用
收藏
页码:847 / 854
页数:7
相关论文
共 41 条
[1]  
Llovet JM(1999)Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 62-67
[2]  
Bustamante J(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer J Hepatol 56 908-943
[3]  
Castells A(2005)The continuing challenge of hepatic cancer in Asia Surgeon. 3 210-215
[4]  
Lai EC(2002)Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective Ann Surg 235 466-486
[5]  
Lau WY(2006)Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus World J Gastroenterol 12 7561-7567
[6]  
Poon RT(2011)A new classification for hepatocellular carcinoma with portal vein tumor thrombus J Hepatobil Pancreat Sci. 18 74-80
[7]  
Fan ST(2012)Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial J Hepatol 57 821-829
[8]  
Tsang FH(2019)Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis J Cell Physiol 234 1062-1070
[9]  
Minagawa M(2016)Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis Medicine (Baltimore). 29 2992-2997
[10]  
Makuuchi M(2012)Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification Med Oncol 6 139-148